CZASF yields 19801.98% · JNJ yields 2.13%● Live data
📍 CZASF pulled ahead of the other in Year 1
Combined, CZASF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CZASF + JNJ for your $10,000?
China ZhengTong Auto Services Holdings Limited, an investment holding company, engages in 4S dealership business in the People's Republic of China. The company operates through 4S Dealership Business, Supply Chain Business, Financial Services Business, and Comprehensive Properties Business segments. It is involved in the sale of motor vehicles and automobile parts; and provision of maintenance and repair services. The company also provides motor-related logistics services; and trades in lubricant oil and auto supplies. In addition, it focuses on the dealership of branded automobiles, including Porsche, BMW, Mercedes-Benz, Audi, Jaguar Land Rover, Hongqi, Volvo, Cadillac, and Infiniti; and operates dealership stores of middle market brands, such as Dongfeng-Nissan, Buick, Dongfeng-Honda, FAW-Volkswagen, Chevrolet, FAW Toyota, and Hyundai. Further, the company engages in the development and sale of real estate properties; property management; trading pre-owned automobiles; e-commerce platform; and provision of consulting and automobile trading agency services, as well as insurance agency services. As of December 31, 2021, it operated 118 dealership outlets in 40 cities across 17 provinces and municipalities. The company was founded in 1999 and is headquartered in Beijing, the People's Republic of China.
Full CZASF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.